Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit-Reference-Cited by-同舟云学术

Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit

Published:2011-03-18 Issue:1 Volume:12 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Royston Patrick,Barthel Friederike M-S,Parmar Mahesh KB,Choodari-Oskooei Babak,Isham Valerie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/article/10.1186/1745-6215-12-81/fulltext.html

Reference20 articles.

1. US Food and Drug Administration: Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. US Dept of Health and Human Services. 2004

2. Proschan MA, Lan KKG, Wittes J: Statistical Monitoring of Clinical Trials - A Unified Approach. 2006, New York: Springer

3. Armitage P, McPherson CK, Rowe BC: Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A. 1969, 132: 235-244. 10.2307/2343787.

4. Lan K, DeMets D: Discrete sequential boundaries for clinical trials. Biometrika. 1983, 70: 659-663. 10.2307/2336502.

5. O'Brien PC, Fleming TR: A multiple testing procedure for clinical trials. Biometrics. 1979, 35: 549-556.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sample Size Reestimation in Stochastic Curtailment Tests With Time‐to‐Events Outcome in the Case of Nonproportional Hazards Utilizing Two Weibull Distributions With Unknown Shape Parameters;Pharmaceutical Statistics;2024-08-18

2. Advantages and Challenges of Platform Trials for Disease Modifying Therapies in Parkinson's Disease;Movement Disorders;2024-06-26

3. A multi‐arm multi‐stage platform design that allows preplanned addition of arms while still controlling the family‐wise error;Statistics in Medicine;2024-06-16

4. Multi-arm multi-stage (MAMS) randomised selection designs: impact of treatment selection rules on the operating characteristics;BMC Medical Research Methodology;2024-06-03

5. Facilities for optimizing and designing multiarm multistage (MAMS) randomized controlled trials with binary outcomes;The Stata Journal: Promoting communications on statistics and Stata;2023-09